Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7717)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2015 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song Y, Shi YH, He C, Liu CQ, Wang JS, Zhao YJ, Guo YM, Wu RJ, Feng XY, Liu ZJ. Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis. World J Gastroenterol 2015; 21(19): 6082-6087 [PMID: 26019477 DOI: 10.3748/wjg.v21.i19.6082] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v21/i19/6082.htm |
| Number | Citing Articles |
| 1 |
Kenichi Kishimoto, Kousaku Kawashima, Mai Fukunaga, Satoshi Kotani, Hiroki Sonoyama, Akihiko Oka, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Noriyoshi Ishikawa, Riruke Maruyama, Shunji Ishihara. Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease. Internal Medicine 2021; 60(3): 385 doi: 10.2169/internalmedicine.5340-20
|
| 2 |
M. Reverte, M. Etienne, M. Fouchard, L. Doucet, E. Brenaut, L. Misery. Occurrence of Henoch–Schönlein purpura in a patient treated with secukinumab. Journal of the European Academy of Dermatology and Venereology 2019; 33(12) doi: 10.1111/jdv.15776
|
| 3 |
Jun Urushikubo, Shunichi Yanai, Shotaro Nakamura, Yosuke Toya, Kensuke Asakura, Takahiro Gonai, Makoto Eizuka, Noriyuki Uesugi, Tamotsu Sugai, Takayuki Matsumoto. IgA vasculitis in a patient with ulcerative colitis under infliximab: drug-induced or genetic?. Clinical Journal of Gastroenterology 2021; 14(1): 198 doi: 10.1007/s12328-020-01280-8
|
| 4 |
Takahiro Inoue, Toshinao Itani, Noriko Inomata, Kazuya Hara, Ikuhisa Takimoto, Shunya Iseki, Kensuke Hamada, Kanna Adachi, Shunsuke Okuyama, Yukari Shimada, Motohito Hayashi, Jun Mimura. <i>Listeria Monocytogenes</i> Septicemia and Meningitis Caused by <i>Listeria</i> Enteritis Complicating Ulcerative Colitis. Internal Medicine 2017; 56(19): 2655 doi: 10.2169/internalmedicine.8654-16
|
| 5 |
Morgane Condamina, Emmanuelle Diaz, Céline Jamart, Jeffrey Loget, Anne Durlach, Jean-Hugues Salmon, Guillaume Cadiot, Manuelle Viguier. Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn’s Disease. Journal of Crohn's and Colitis 2020; 14(4): 538 doi: 10.1093/ecco-jcc/jjz164
|
| 6 |
Bayram Farisogullari, Muserref Kasap Cuceoglu, Hakan Oral, Gozde Kubra Yardimci, Yelda Bilginer, Seza Ozen, Omer Karadag. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?. Internal and Emergency Medicine 2022; 17(6): 1599 doi: 10.1007/s11739-022-02968-0
|
| 7 |
Kimberly Darlington, Paul Googe, Priyanka Vedak, Animesh Jain, Millie D. Long, Edward L. Barnes, Hans H. Herfarth. Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease. Digestive Diseases and Sciences 2023; 68(7): 2861 doi: 10.1007/s10620-023-07934-0
|
| 8 |
Bo Shen. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. 2018; : 295 doi: 10.1016/B978-0-12-811388-2.00026-9
|
| 9 |
Camila da Silva Cendon Duran, Adriane Souza da Paz, Mittermayer Barreto Santiago. Vasculitis induced by biological agents used in rheumatology practice: A systematic review. Archives of Rheumatology 2022; 37(2): 300 doi: 10.46497/ArchRheumatol.2022.9049
|
| 10 |
M Villatoro-Villar, CS Crowson, KJ Warrington, A Makol, MJ Koster. Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort study. Scandinavian Journal of Rheumatology 2021; 50(1): 40 doi: 10.1080/03009742.2020.1732460
|
| 11 |
|
| 12 |
Aliki I. Venetsanopoulou, Konstantina Mavridou, Paraskevi V. Voulgari, Alexandros A. Drosos. Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations. Seminars in Arthritis and Rheumatism 2023; 63: 152272 doi: 10.1016/j.semarthrit.2023.152272
|
| 13 |
N. Urganci, M. Sakar, O. Yalcín, D. Kalyoncu. Púrpura de Henoch-Schönlein inducida por infliximab para enfermedad de Crohn: reporte de un caso y revisión de la literatura. Revista de Gastroenterología de México 2022; 87(1): 110 doi: 10.1016/j.rgmx.2020.12.004
|
| 14 |
Karen A. Chachu, Mark T. Osterman. How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD. Inflammatory Bowel Diseases 2016; 22(5): 1262 doi: 10.1097/MIB.0000000000000726
|
| 15 |
N. Urganci, M. Sakar, O. Yalcín, D. Kalyoncu. Henoch-Schönlein purpura induced by infliximab for Crohn’s disease: A case report and literature review. Revista de Gastroenterología de México (English Edition) 2022; 87(1): 110 doi: 10.1016/j.rgmxen.2021.10.005
|
| 16 |
Shintaro Yamamoto, Tomoyuki Mukai, Shunichi Fujita, Yoshitaka Morita. Certolizumab pegol-induced immunoglobulin A vasculitis in a patient with rheumatoid arthritis. Medicine: Case Reports and Study Protocols 2021; 2(1): e0029 doi: 10.1097/MD9.0000000000000029
|